| 2023-04-28 |
详情>>
股本变动：
变动后总股本870.31万股
|
| 2023-03-20 |
详情>>
业绩披露：
2022年年报每股收益-15.81美元,归母净利润-1.03亿美元,同比去年增长48.23%
|
| 2023-02-15 |
详情>>
拆分方案：
每20.0000合并分成1.0000股
|
| 2022-11-03 |
详情>>
业绩披露：
2022年三季报(累计)每股收益-0.57美元,归母净利润-6924.6万美元,同比去年增长27.40%
|
| 2022-11-03 |
财报披露：
美东时间 2022-11-03 盘前发布财报
|
| 2022-10-11 |
股东大会：
将于2022-11-22召开股东大会
会议内容 ▼▲
- 1.To approve an amendment to the Company’s Amended and Restated Certificate of Incorporation to effect an increase in the total number of authorized shares of common stock, par value $0.001 per share, of the Company from 250,000,000 shares to 500,000,000 shares;
2.To approve an amendment to the Company’s Amended and Restated Certificate of Incorporation, at the discretion of the Board, to effect a reverse stock split of the issued and outstanding shares of Common Stock in a range of not less than one-for-five shares and not more than one-for-twenty shares, with a corresponding reduction in the total number of authorized shares of common stock in proportion to the reduction of the issued and outstanding shares, to enable the Company to comply with the Nasdaq continued listing requirements;
3.To approve the Second Amendment to the Amended and Restated 2017 Omnibus Incentive Plan.
|
| 2022-07-29 |
详情>>
业绩披露：
2022年中报每股收益-0.44美元,归母净利润-4957.7万美元,同比去年增长16.43%
|
| 2022-05-10 |
详情>>
业绩披露：
2022年一季报每股收益-0.16美元,归母净利润-1742万美元,同比去年增长30.46%
|
| 2022-04-28 |
股东大会：
将于2022-06-10召开股东大会
会议内容 ▼▲
- 1.To elect the Class II nominees named in the proxy statement as directors for a three-year term expiring in 2025 and until their successors have been duly elected and qualified;
2.To approve, on an advisory basis, the compensation paid to our named executive officers;
3.To ratify the appointment of Deloitte & Touche LLP as our Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022;
4.To approve the issuance of shares as milestone payments under the agreement and plan of merger with Kuur Therapeutics, Inc. in accordance with Nasdaq Rule 5635;
5.To consider and take action upon such other matters as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2022-03-16 |
详情>>
业绩披露：
2019年年报每股收益-1.67美元,归母净利润-1.24亿美元,同比去年增长-5.37%
|
| 2022-03-16 |
详情>>
业绩披露：
2021年年报每股收益-1.92美元,归母净利润-2亿美元,同比去年增长-36.66%
|
| 2021-11-04 |
详情>>
业绩披露：
2021年三季报(累计)每股收益-0.93美元,归母净利润-9538.1万美元,同比去年增长1.35%
|
| 2021-11-04 |
详情>>
业绩披露：
2020年三季报(累计)每股收益-1.17美元,归母净利润-9668.6万美元,同比去年增长5.23%
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-08-05 |
详情>>
业绩披露：
2021年中报每股收益-0.6美元,归母净利润-5932.4万美元,同比去年增长0.93%
|
| 2021-05-06 |
详情>>
业绩披露：
2021年一季报每股收益-0.27美元,归母净利润-2505万美元,同比去年增长-28.93%
|
| 2021-04-29 |
股东大会：
将于2021-06-18召开股东大会
会议内容 ▼▲
- 1.To elect the Class I nominees named in the proxy statement as directors for a three-year term expiring in 2024 and until their successors have been duly elected and qualified;
2.To approve, on an advisory basis, the compensation paid to our named executive officers;
3.To approve the Amendment to the Amended and Restated 2017 Omnibus Incentive Plan;
4.To ratify the appointment of Deloitte & Touche LLP as our Company’s independent registered public accounting firm for the fiscal year ending December 31, 2021;
5.To consider and take action upon such other matters as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2021-03-01 |
复牌提示：
2021-03-01 06:55:18 停牌，复牌日期 2021-03-01 07:35:00
|
| 2021-03-01 |
详情>>
业绩披露：
2020年年报每股收益-1.72美元,归母净利润-1.46亿美元,同比去年增长-18.13%
|
| 2020-04-15 |
股东大会：
将于2020-06-05召开股东大会
会议内容 ▼▲
- 1.To elect the Class III nominees named in the proxy statement as directors for a three-year term expiring in 2023 and until their successors have been duly elected and qualified;
2.To approve, on an advisory basis, the compensation paid to our named executive officers;
3.To select, on an advisory basis, the frequency of future advisory votes on the compensation of our named executive officers;
4.To approve the Amended and Restated 2017 Omnibus Incentive Plan;
5.To ratify the appointment of Deloitte & Touche LLP as our Company’s independent registered public accounting firm for the fiscal year ending December 31, 2020;
6.To consider and take action upon such other matters as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2019-04-25 |
股东大会：
将于2019-06-11召开股东大会
会议内容 ▼▲
- 1.To elect the Class II directors named in the Proxy Statement for a three-year term expiring in 2022 and until their successors have been elected and qualified or, if sooner, until their death, resignation or removal;
2.To ratify the appointment of Deloitte & Touche LLP as our Company’s independent registered public accounting firm for the fiscal year ending December 31, 2019;
3.To consider and take action upon such other matters as properly come before the meeting or any adjournment or postponement thereof.
|
| 2018-08-20 |
详情>>
内部人交易：
WU JINN股份增加5000.00股
|
| 2018-04-30 |
股东大会：
将于2018-06-12召开股东大会
会议内容 ▼▲
- 1.To elect the Class I directors named in the Proxy Statement for a three-year term expiring in 2021 and until their successors have been elected and qualified or, if sooner, until their death, resignation or removal;
2.To ratify the appointment of Deloitte & Touche LLP as our Company’s independent registered public accounting firm for the fiscal year ending December 31, 2018;
3.To consider and take action upon such other matters as properly comes before the meeting or any adjournment or postponement thereof.
|